Skip to content

Physical Therapy Following Total Hip Arthroplasty

Randomized Controlled Trial of Home-based Physical Therapy Versus Outpatient Clinic-based Physical Therapy Following Primary Anterior Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04199390
Enrollment
130
Registered
2019-12-13
Start date
2018-07-31
Completion date
2019-10-07
Last updated
2019-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Surgery

Keywords

total hip arthroplasty, physical therapy

Brief summary

130 patients undergoing primary unilateral total hip arthroplasty through anterior approach were enrolled and randomized into one of two groups. One group received standard of care clinic-based physical therapy postoperatively (clinic PT) while the other group underwent progressive home-based exercises to do after surgery (home PT). Patient surveys with Hip Osteoarthritis Outcome Scores (HOOS) and SF12v2 scores for both groups were obtained before surgery as well as 6, 14, and 24 weeks postop. Patients had the option to crossover into the other study group at their 6-week follow-up visit.

Interventions

PROCEDUREtotal hip arthroplasty

each patient is expected to undergo an anterior total hip arthroplasty procedure and some sort of physical therapy postoperatively

Sponsors

Medacta USA
CollaboratorINDUSTRY
Orthopedic One
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* scheduled to undergo primary unilateral anterior total hip arthroplasty for the treatment of arthritis under the care of the Principal investigator * available for follow ups postoperatively

Exclusion criteria

* Age \<18 or \> 75 * Preoperative BMI ≥ 40 * Revision (i.e., non-primary) THA procedures * Patients who have undergone THA in contralateral hip within the past 6 months * Patient is scheduled for or anticipating THA on contralateral limb within 6 months * Patients with an active infection (at the time of screening through surgery, as this is a surgical contraindication) * Current co-morbidities such as alcohol or drug addiction, and/or mental disorders could potentially interfere with study participation * Cognitive deficit or significant mental impairment that would, in the opinion of the investigator, impede patient self-reporting * History of severe osteoporosis, metabolic bone disease, radioactive bone disease, or tumor in the bone surrounding the hip joint * History of significant neurological and/or musculoskeletal disorders that may adversely affect gait after THA * History of inflammatory hip arthritis * History of septic hip arthritis in affected hip * Patients requiring discharge to a rehabilitation center, skilled nursing facility, long-term care center, or convalescent home * Non-English speaking * Unable to give informed consent * Currently enrolled in another therapeutic study for THA

Design outcomes

Primary

MeasureTime frame
Change in Hip Disability and Osteoarthritis Outcome Scorespreoperative, postoperative 6 weeks, postoperative 12 weeks, and postoperative 24 weeks
Change in SF-12v2 Scorespreoperative and postoperative 24 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026